NTF4 and cancer: NT4 binding was abolished by heparin in both cell lines, and was also inhibited by the known heparin-binding proteins Midkine and, to a lower extent, Apolipoprotein E4, in line with what we had reported with different human cancer cell lines [16], demonstrating specific recognition of NT4 membrane targets.